Author:
Schneider Uwe,Besserer Jürgen,Mack Andreas
Publisher
Springer Science and Business Media LLC
Subject
Health Informatics,Modeling and Simulation
Reference15 articles.
1. Brown SL, Rodger A, Orton CG: Point/Counterpoint. Hypofractionation is a proven safe and effective modality for postoperative whole-breast radiotherapy for early breast cancer patients. Med Phys. 2009, 36 (6): 1927-30. 10.1118/1.3116462.
2. Whelan TJ, Kim DH, Sussman J: Clinical experience using hypofractionated radiation schedules in breast cancer. Semin Radiat Oncol. 2008, 18 (4): 257-64. 10.1016/j.semradonc.2008.04.008.
3. Bartelink H, Arriagada R: Hypofractionation in radiotherapy for breast cancer. Lancet. 2008, 371 (9618): 1050-2. 10.1016/S0140-6736(08)60349-9.
4. START Trialists' Group, Bentzen SM, Agrawal RK, Aird EG, Barrett JM, Barrett-Lee PJ, Bentzen SM, Bliss JM, Brown J, Dewar JA, Dobbs HJ, Haviland JS, Hoskin PJ, Hopwood P, Lawton PA, Magee BJ, Mills J, Morgan DA, Owen JR, Simmons S, Sumo G, Sydenham MA, Venables K, Yarnold JR: The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet. 2008, 29;371 (9618): 1098-107.
5. Macías V, Biete A: Hypofractionated radiotherapy for localised prostate cancer. Review of clinical trials. Clin Transl Oncol. 2009, 11 (7): 437-45. 10.1007/s12094-009-0382-2.
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献